Project Details
Short title | Efficacy and safety of bumetanide oral liquid formulation in children and adolescents aged from 7 to less than 18 years old with Autism Spectrum Disorder |
---|---|
Status | Finished |
Effective start/end date | 1/01/19 → 31/12/21 |
Funding
- BIRMINGHAM WOMENS NHS TRUST